198 related articles for article (PubMed ID: 33839207)
1. Establishment and validation of a prognostic nomogram to predict early metastasis in nasopharyngeal carcinoma patients within six months after radiotherapy and to guide intensive treatment.
Lu ZJ; Liu LT; Sun XS; Guo SS; Yang Q; Liu SL; Li XY; Qiu HZ; Yang ZC; Xiao BB; Lin C; Luo DH; Sun R; Lin HX; Chen QY; Tang LQ; Guo L; Mai HQ
Radiother Oncol; 2021 Sep; 162():202-211. PubMed ID: 33839207
[TBL] [Abstract][Full Text] [Related]
2. Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma.
Tang LQ; Li CF; Li J; Chen WH; Chen QY; Yuan LX; Lai XP; He Y; Xu YX; Hu DP; Wen SH; Peng YT; Zhang L; Guo SS; Liu LT; Guo L; Wu YS; Luo DH; Huang PY; Mo HY; Xiang YQ; Sun R; Chen MY; Hua YJ; Lv X; Wang L; Zhao C; Cao KJ; Qian CN; Guo X; Zeng YX; Mai HQ; Zeng MS
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26467665
[TBL] [Abstract][Full Text] [Related]
3. Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model.
Sun XS; Xiao ZW; Liu SL; Sun R; Luo DH; Chen QY; Mai HQ
Eur Radiol; 2023 May; 33(5):3682-3692. PubMed ID: 36735041
[TBL] [Abstract][Full Text] [Related]
4. Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.
Fei Z; Qiu X; Li M; Chen C; Li Y; Huang Y
Jpn J Clin Oncol; 2020 Feb; 50(2):159-168. PubMed ID: 31711182
[TBL] [Abstract][Full Text] [Related]
5. The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Wan Y; Tian L; Zhang G; Xin H; Li H; Dong A; Liang Y; Jing B; Zhou J; Cui C; Chen M; Sun Y; Xie C; Liu L; Shao Y
Radiother Oncol; 2019 Feb; 131():35-44. PubMed ID: 30773185
[TBL] [Abstract][Full Text] [Related]
6. Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT.
Xiao BB; Lin DF; Sun XS; Zhang X; Guo SS; Liu LT; Luo DH; Sun R; Wen YF; Li JB; Lv XF; Han LJ; Yuan L; Liu SL; Tang QN; Liang YJ; Li XY; Guo L; Chen QY; Fan W; Mai HQ; Tang LQ
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2586-2598. PubMed ID: 33420610
[TBL] [Abstract][Full Text] [Related]
7. Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma.
Wu S; Yuan X; Huang H; Li Y; Cui L; Lin D; Lu W; Feng H; Chen Z; Liu X; Tan J; Wang F
BMC Cancer; 2023 Dec; 23(1):1217. PubMed ID: 38066499
[TBL] [Abstract][Full Text] [Related]
8. Significance of radiologic extranodal extension in locoregionally advanced nasopharyngeal carcinoma with lymph node metastasis: a comprehensive nomogram.
Ding J; Chen J; Lin Y; Hong J; Huang C; Fei Z; Chen C
Braz J Otorhinolaryngol; 2024; 90(2):101363. PubMed ID: 38101121
[TBL] [Abstract][Full Text] [Related]
9. Establishment and validation of a nomogram for predicting the benefit of concurrent chemotherapy in stage II nasopharyngeal carcinoma: A study based on a phase III randomized clinical trial with 10-year follow-up.
Sun XS; Li XY; Xiao BB; Liu SL; Chen QY; Tang LQ; Mai HQ
Oral Oncol; 2020 Jan; 100():104490. PubMed ID: 31790913
[TBL] [Abstract][Full Text] [Related]
10. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract][Full Text] [Related]
11. Prognostic nomogram to predict the distant metastasis after intensity-modulated radiation therapy for patients with nasopharyngeal carcinoma.
Mi JL; Xu M; Liu C; Wang RS
Medicine (Baltimore); 2021 Nov; 100(47):e27947. PubMed ID: 34964774
[TBL] [Abstract][Full Text] [Related]
12. Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose.
Huang YY; Zhou JY; Zhan ZJ; Ke LR; Xia WX; Cao X; Cai ZC; Deng Y; Chen X; Zhang LL; Huang HY; Guo X; Lv X
BMC Cancer; 2023 May; 23(1):410. PubMed ID: 37149594
[TBL] [Abstract][Full Text] [Related]
13. MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it.
Li WZ; Liu GY; Lin LF; Lv SH; Qiang MY; Lv X; Wu YS; Liang H; Ke LR; Wang DL; Yu YH; Qiu WZ; Liu KY; Guo X; Li JP; Zou YJ; Xiang YQ; Xia WX
Radiother Oncol; 2020 Apr; 145():101-108. PubMed ID: 31931288
[TBL] [Abstract][Full Text] [Related]
14. Integrating pretreatment MRI-detected nodal features and Epstein-Barr virus DNA to identify optimal candidates for intensity-modulated radiotherapy alone in patients with stage II nasopharyngeal carcinoma.
Guo J; He Y; Lin C; Jiang Q; Xing HW; Zhang YC; Shen GZ; Lin HX; Guo L; Yang Q
Oral Oncol; 2023 Nov; 146():106574. PubMed ID: 37741017
[TBL] [Abstract][Full Text] [Related]
15. Nomogram to Predict Long-Term Overall Survival and Cancer-Specific Survival of Radiotherapy Patients with Nasopharyngeal Carcinoma.
Li Z; Li C; Yang D; Zhou Z; Kang M
Biomed Res Int; 2023; 2023():7126881. PubMed ID: 36704722
[TBL] [Abstract][Full Text] [Related]
16. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
[TBL] [Abstract][Full Text] [Related]
17. Establishment and validation of a novel nomogram to predict overall survival in nasopharyngeal carcinoma with lymph node metastasis.
Li W; Lu H; Wang H; Hu L; Sun X; Yu H; Wang D
Head Neck; 2021 Aug; 43(8):2353-2363. PubMed ID: 33780078
[TBL] [Abstract][Full Text] [Related]
18. A nomogram based on nutritional and inflammatory parameters to predict DMFS and identify beneficiaries of adjuvant chemotherapy in IVA-stage nasopharyngeal carcinoma.
Pan Y; Chen Z; Hong W; Huang Z; Li Y; Cai S; Lai J; Lu J; Qiu S
BMC Cancer; 2024 May; 24(1):578. PubMed ID: 38734620
[TBL] [Abstract][Full Text] [Related]
19. Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II-IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort.
Sun XS; Xiao BB; Lin C; Liu SL; Chen QY; Tang LQ; Mai HQ
Cancer Med; 2020 Mar; 9(5):1661-1670. PubMed ID: 31925942
[TBL] [Abstract][Full Text] [Related]
20. Regional lymph node density-based nomogram predicts prognosis in nasopharyngeal carcinoma patients without distant metastases.
Ma J; Zhao R; Wu YL; Liu Y; Jin GQ; Su DK
Cancer Imaging; 2023 Dec; 23(1):123. PubMed ID: 38102725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
